immagine

Attività svolta

Desidero ricevere una copia cartacea
Informativa sulla privacy
Iscrizione alla newsletter

Integratori, acidi grassi essenziali, prebiotici e probiotici: cosa sono e quando si utilizzano nelle malattie cutanee del cane

Per saperne di più

 

1.Marsella, R.; Olivry, T.; Carlotti, D.N. Current evidence of skin barrier dysfunction in human and canine atopic dermatitis. Vet. Dermatol. 2011, 22, 239-248.

2. Woldemeskel, M. Nutraceuticals in dermatological disorders. In Nutraceuticals in Veterinary Medicine; Springer: Cham, Switzerland, 2019; pp. 563-568.

3. Olivry, T.; Mueller, R.S. International task force on canine atopic dermatitis. Evidence-based veterinary dermatology: A systematic review of the pharmacotherapy of canine atopic dermatitis. Vet. Dermatol. 2003, 14, 121-146.

4. Hillier, A.; Griffin, C.E. The ACVD task force on canine atopic dermatitis (I): Incidence and prevalence. Vet. Immunol. Immunopathol. 2001, 81, 147-151.

5. Watson, T.D.G. Diet and skin disease in dogs and cats. J. Nutr. 1998, 128, 2783S-2789S.

6. Olivry, T.; Bizikova, P. A systematic review of randomized controlled trials for prevention or treatment of atopic dermatitis in dogs: 2008-2011 update. Vet. Dermatol. 2013, 24, 97-e26

7. Mazzeranghi, F.; Zanotti, C.; Di Cerbo, A.; Verstegen, J.P.; Cocco, R.; Guidetti, G.; Canello, S. Clinical efficacy of nutraceutical diet for cats with clinical signs of cutaneus adverse food reaction (CAFR). Pol. J. Vet. Sci.2017, 20, 269-276.

8. Bíró, T.; Tóth, B.; Haskó, G.; Paus, R.; Pacher, P. The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities. Trends Pharmacol. Sci. 2009, 30, 411-420.

9. Abramo, F.; Campora, L.; Albanese, F.; della Valle, M.F.; Cristino, L.; Petrosino, S.; Di Marzo, V.; Miragliotta, V. Increased levels of palmitoylethanolamide and other bioactive lipid mediators and enhanced local mast cell proliferation in canine atopic dermatitis. BMC Vet. Res. 2014, 10, 21.

10. Abramo, F.; Salluzzi, D.; Leotta, R.; Auxilia, S.; Noli, C.; Miolo, A.; MAntis, P.; DH, L. Mast cell morphometry and densitometry in experimental skin wounds treated with a gel containing adelmidrol: A placebo controlled study. Wounds Compend. Clin. Res. Pract. 2008, 20, 149-157.

11. Noli, C.; Miolo, A. Aliamidi in dermatologia veterinaria. Review delle evidenze pre-cliniche e cliniche. Veterinaria 2012, 26, 9-19.

12. Schumann, J.; Basiouni, S.; Gück, T.; Fuhrmann, H. Treating canine atopic dermatitis with unsaturated fatty acids: The role of mast cells and potential mechanisms of action. J. Anim. Physiol. Anim. Nutr. 2014, 98, 1013-1020.

13. Saevik, B.K.; Bergvall, K.; Holm, B.R.; Saijonmaa-Koulumies, L.E.; Larsen, S.; Kristensen, F. A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Vet. Dermatol. 2004, 15, 137-145.

14. Nesbitt, G.H.; Freeman, L.M.; Hannah, S.S. Correlations of fatty acid supplementation, aeroallergens, shampoo, and ear cleanser with multiple parameters in pruritic dogs. J. Am. Anim. Hosp. Assoc. 2004, 40, 270-284.

15. Mueller, R.S.; Fieseler, K.V.; Fettman, M.J.; Zabel, S.; Rosychuk, R.A.W.W.; Ogilvie, G.K.; Greenwalt, T.L. Effect of omega-3 fatty acids on canine atopic dermatitis. J. Small Anim. Pract. 2004, 45, 293-297.

16. Müller, M.R.; Linek, M.; Löwenstein, C.; Röthig, A.; Doucette, K.; Thorstensen, K.; Mueller, R.S. Evaluation of cyclosporine-sparing effects of polyunsaturated fatty acids in the treatment of canine atopic dermatitis. Vet. J.2016, 210, 77-81.

17. Jeong, S.J.; Lim, H.S.; Seo, C.S.; Kim, J.H.; Jin, S.E.; Yoo, S.R.; Shin, H.K. Traditional herbal formula Jakyakgamcho-tang (Paeonia lactiflora and Glycyrrhiza uralensis) impairs inflammatory chemokine production by inhibiting activation of STAT1 and NF-κB in HaCaT cells. Phytomedicine 2015, 22, 326-332.

18. Ferguson, E.A.; Littlewood, J.D.; Carlotti, D.N.; Grover, R.; Nuttall, T. Management of canine atopic dermatitis using the plant extract PYM00217: A randomized, double-blind, placebo-controlled clinical study. Vet. Dermatol. 2006, 17, 236-243.

19.  Lee, S.E.; Hwang, H.J.; Ha, J.S.; Jeong, H.S.; Kim, J.H. Screening of medicinal plant extracts for antioxidant activity. Life Sci. 2003, 73, 167-179.

20. Kim, M.C.; Lee, C.H.; Yook, T.H. Effects of anti-inflammatory and rehmanniae radix pharmacopuncture on atopic dermatitis in NC/Nga mice. J. Acupunct. Meridian Stud. 2013, 6, 98-109.

21. Barakat, A.Z.; Hamed, A.R.; Bassuiny, R.I.; Abdel-Aty, A.M.; Mohamed, S.A. Date palm and saw palmettoseeds functional properties: Antioxidant, anti-inflammatory and antimicrobial activities. J. Food Meas. Charact. 2020, 14, 1064-1072.

22. Barsanti, J.A.; Finco, D.R.; Maha ey, M.M.; Fayrer-Hosken, R.A.; Crowell, W.A.; Thompson, F.N.; Shotts, E.B.Effects of an extract of serenoa repens on dogs with hyperplasia of the prostate gland. Am. J. Vet. Res. 2000,61, 880-885.

23. Craig, J.M. Atopic dermatitis and the intestinal microbiota in humans and dogs. Vet. Med. Sci. 2016, 2, 95-105.

24. Notay, M.; Foolad, N.; Vaughn, A.R.; Sivamani, R.K. Probiotics, Prebiotics, and synbiotics for the treatment and prevention of adult dermatological diseases. Am. J. Clin. Dermatol. 2017, 18, 721-732.

25. Holowacz, S.; Blondeau, C.; Guinobert, I.; Guilbot, A.; Hidalgo, S.; Bisson, J.F. Lactobacillus salivarius LA307 and Lactobacillus rhamnosus LA305 attenuate skin inflammation in mice. Benef. Microbes 2018, 9, 299-309.

26. Marsella, R. Evaluation of Lactobacillus rhamnosus strain GG for the prevention of atopic dermatitis in dogs. Am. J. Vet. Res. 2009, 70, 735-740.

27. Marsella, R.; Santoro, D.; Ahrens, K. Early exposure to probiotics in a canine model of atopic dermatitis has long-term clinical and immunological e ects. Vet. Immunol. Immunopathol. 2012, 146, 185-189.

28. Logas, D.; Kunkle, G.A.; Mcdowell, L. Comparison of serum zinc levels in healthy, systemically ill and dermatologically diseased dogs. Vet. Dermatol. 1993, 4, 61-64.

29. White, S.D.; Bourdeau, P.; Rosychuk, R.A.W.; Cohen, B.; Bonenberger, T.; Fieseler, K.V.; Ihrke, P.; Chapman, P.L.; Schultheiss, P.; Zur, G.; et al. Zinc-responsive dermatosis in dogs: 41 cases and literature review. Vet. Dermatol. 2001, 12, 101-109. Vet. Sci. 2020, 7, 38 14 of 14.

30. McFadden, R.A.; Heinrich, N.A.; Haarstad, A.C.; Tomlinson, D.J. A double-blinded, randomized, controlled, crossover evaluation of a zinc methionine supplement as an adjunctive treatment for canine atopic dermatitis. Vet. Dermatol. 2017, 28, 569-e138.

 

TORNA INDIETRO
Abbonati per accedere

Dal web internazionale
27/01/2026

Patologia comparata del tumore alla prostata del cane e dell'uomo

Sebbene relativamente raro nei cani, il cancro alla prostata (PCa) è il tumore non cutaneo più comune negli uomini. Le ghiandole prostatiche umane e canine condividono molte caratteristiche funzionali, anatomiche e fisiologiche. A causa di queste somiglianze, il PCa canino è stato proposto come modello per il PCa negli uomini.

 
 
Formazione a distanza abbinata a SUMMA

SPC-sviluppo-professionale-continuo